Mental Health Screening Market

Mental Health Screening Market Size by Indication (Depression, Bipolar, Schizophrenia, ADHD, Alzheimer, Dementia), Screening (Self, Interview, Observation, Biomarker), Technology (mHealth, Remote Platform, Telehealth), Age, Setting & Region - Global Forecast to 2029

Report Code: HIT 8966 Mar, 2024, by marketsandmarkets.com

The global size of mental health screening market in terms of revenue was estimated to be worth USD 0.9 billion in 2023 and is poised to reach USD 1.8 billion by 2029, growing at a CAGR of 12.2% from 2023 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Growth of mental health screening industry is mainly driven by the rising awareness of mental health issues, increasing focus on remote monitoring, and technological advancements.

Mental Health Screening Market

Health Screening Market

To know about the assumptions considered for the study, Request for Free Sample Report

Health Screening Market

Mental Health Screening Market Dynamics

DRIVER: Rising awareness of mental health issues

The growing awareness about mental health issues has been a significant driving force behind the increased adoption of mental health screening tools and solutions. In the past decade, there has been a notable shift in societal attitudes towards mental health, with heightened recognition of its prevalence and impact.

  • According to the World Health Organization (WHO), in 2019, approximately 1 in every 8 people (970 million people) worldwide were living with a mental disorder.
  • Initiatives like "Bell Let's Talk" in Canada and "Mental Health Awareness Month" in the US have gained widespread traction, fostering dialog and encouraging individuals to seek support.
  • According to a Healthy Now survey conducted by Parade Media and Cleveland in 2021, 82% of Americans agree that mental health is just as important as physical health. This represents a notable rise from the 68% who strongly concurred with this sentiment in 2018.
  • According to a 2022 survey by the National Alliance on Mental Illness (NAMI), 73% of Americans believe that the stigma surrounding mental illness has decreased in the past five years.

This increased awareness has increased the demand for mental health resources, including screening tools, as individuals seek to proactively manage their well-being.

RESTRAINT: Stigma and limited awareness

The stigma surrounding mental health continues to be a significant barrier to the widespread adoption and effective utilization of mental health screening tools and solutions. Despite efforts to raise awareness and reduce this stigma, societal misconceptions and negative attitudes towards mental illness persist, hindering individuals from seeking help and utilizing screening resources.

A 2023 survey by NAMI found that 44% of Americans with mental illness reported experiencing discrimination due to their condition. This stigma often creates a significant barrier to individuals seeking help. Fear of judgment, discrimination, and negative consequences often leads to avoidance of screening and treatment, delaying interventions and potentially worsening symptoms. This exacerbates the severity of mental health conditions and reduces the effectiveness of screening interventions.

Moreover, limited awareness about mental health and available screening tools further contributes to the underutilization of mental health resources. Many individuals may not recognize the signs and symptoms of mental illness or understand the importance of early intervention and screening.

OPPORTUNITY: Increase in number of clinical trials

The emergence of social media platforms presents a significant opportunity to increase the adoption and utilization of mental health screening tools and solutions. Social media has become an integral part of the daily lives of billions of people worldwide, offering unprecedented access to information, support networks, and peer communities. According to a 2023 survey by The Trevor Project, 76% of LGBTQ+ youth utilize social media to find information and support regarding mental health. Social media platforms can be powerful tools for spreading awareness about mental health conditions, destigmatizing seeking help, and fostering open conversations. This can encourage individuals to explore screening tools as a means to monitor their well-being. Moreover, social media provides a platform for sharing personal stories, experiences, and testimonials related to mental health, which can help normalize discussions around mental illness and encourage help-seeking behaviors. By harnessing the reach and influence of social media platforms, mental health screening tools and solutions can effectively reach and engage individuals, ultimately improving access to care and promoting early intervention for mental health disorders.

CHALLENGE: Concerns regarding accuracy and validity

One of the most significant challenges facing mental health screening tools and solutions is the concern regarding their accuracy and validity. While these tools aim to provide valuable insights into individuals' mental well-being, there are concerns about their reliability in accurately identifying and assessing mental health conditions. According to a study published in the Journal of the American Medical Association (JAMA), researchers found significant variability in the accuracy of popular mental health screening apps, with some apps demonstrating poor sensitivity and specificity in detecting mental health disorders. Furthermore, there are concerns about the lack of standardized guidelines and validation processes for mental health screening tools. Without rigorous validation and testing procedures, there is a risk that screening tools may produce inconsistent or inaccurate results, leading to false positives or false negatives.

Mental health screening Industry Ecosystem

The mental health screening market ecosystem comprises entities responsible for the end-to-end workflow of screening mental issues.

The stakeholders present in this market include developers and providers of screening tools, telehealth & virtual care platforms, health providers & institutions, health insurance & payer organizations, research & academic institutions, and regulatory & compliance bodies.

DEVELOPERS & PROVIDERS OF SCREENING TOOLS

  • These companies design, develop, and distribute mental health screening tools, including apps, software, and digital platforms.
  • They offer innovative and accessible tools for early detection and intervention.

TELEHEALTH & VIRTUAL CARE PLATFORMS

  • These platforms facilitate remote access to mental health screening, assessment, and counseling services.
  • They increase access to care, especially in underserved areas or for individuals with mobility constraints.

HEALTH PROVIDERS & INSTITUTIONS

  • These organizations integrate mental health screening tools into their care delivery models.
  • They enhance patient care by identifying mental health issues early and connecting individuals with appropriate resources.

HEALTH INSURANCE & PAYER ORGANIZATIONS

  • These companies may cover mental health screening services and provide incentives for using certain screening tools.
  • They improve affordability and incentivize preventive care, reducing long-term healthcare costs.

RESEARCH & ACADEMIC INSTITUTIONS

  • These institutions contribute to developing and validating mental health screening tools through research and clinical trials.
  • They conduct research and clinical trials to validate screening tools and advance mental health knowledge.
  • They drive innovation, improve tool effectiveness, and contribute to evidence-based practices.

REGULATORY & COMPLIANCE BODIES

  • These organizations establish guidelines and standards for developing and using mental health screening tools.
  • They ensure quality, safety, and patient privacy, fostering trust in screening tools and promoting responsible use.

Attention deficit hyperactivity disorder (ADHD) is the largest psychiatric disorder of the mental health screening industry in 2022.

Based on applications, the mental health screening market is segmented into physiological, psychiatric, behavioral, and cognitive disorders. Psychiatric disorders are further segmented into schizophrenia, psychotic disorder, dissociative disorder, obsessive compulsive disorder, dissociative disorder, attention deficit hyperactivity disorder (ADHD), and other psychiatric disorders.

Among psychiatric disorders, attention deficit hyperactivity disorder (ADHD) sub-segment dominates the market in 2022, attributing to several factors. The cases and diagnoses of ADHD have been increasing due to growing awareness about ADHD. These factors contribute to an increased demand for ADHD screening.

The self-reported questionnaires & surveys segment is expected to grow at the highest CAGR from 2024 to 2029 in the mental health screening industry.

Based on screening methods, the global mental health screening market is segmented into self-reported questionnaires & surveys, clinical interviews, observation-based assessments, and biomarker testing. The self-reported questionnaires & surveys segment is expected to register the highest growth rate during the forecast period. Wide variety of questionnaires at affordable prices over digital platforms and availability of self-reported questionnaires & surveys in multilingual formats are the key factors driving the adoption of self-reported questionnaire-based assessments in mental health screening.

The online platforms segment is expected to grow at the highest CAGR from 2024 to 2029 in the mental health screening industry.

Based on setting, the Mental Health Screening market is segmented into clinical settings, educational institutions, workplace/corporate programs, online platforms, and other settings. The online platforms segment is expected to register the highest growth rate in the forecast period attributing to the availability of personalized assessments for the mental health status and needs of the users.

North America accounted for the largest share of the mental health screening industry in 2023.

Based on the region, the mental health screening market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America accounted for the largest share of the market in 2023. This is due to the growing number of people requiring mental health services, health reforms in the US, and government funding for mental health services in the region.

Health Screening Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Prominent players in Mental health screening market include Proem Behavioral Health (US), SonderMind Inc. (US), Riverside Community Care (US), Headspace Health (US), Quartet Health, Inc. (US), Canary Speech, Inc. (US), Sonde Health, Inc. (US), Koninklijke Philips N.V. (Netherlands), Alphabet Inc. (Fitbit) (US), ResMed (US), Apple Inc. (US), Wellin5 USA Inc. (Canada), Clarigent Health (US), Woebot Labs Inc. (US), Aiberry (US), Cognitive Health Solutions, LLC (US), Adaptive Testing Technologies (US), Thymia Limited (UK), Modern Life, Inc. (US), MoodFit (US), MoodTools (US), Kintsugi Mindful Wellness, Inc. (US), Ellipsis Health Inc. (US), FuturesTHRIVE (US), and CogniABle (India).

Scope of the Mental Health Screening Industry

Report Metric

Details

Market Revenue in 2023

$0.9 billion

Projected Revenue by 2029

$1.8 billion

Revenue Rate

Poised to Grow at a CAGR of 12.2%

Market Driver

Rising awareness of mental health issues

Market Opportunity

Increase in number of clinical trials

The study categorizes the Mental Health Screening market to forecast revenue and analyze trends in each of the following submarkets:

By Application

  • Software
  • Services
  • Wearables, Mobile and Other Devices
  • Physiological Disorders
    • Depression
    • Anxiety
    • Post-Traumatic Stress Disorder (PTSD)
    • Bipolar Disorder
    • Eating Disorder
    • Substance Abuse
    • Other Physiological Disorders
  • Psychiatric Disorders
    • Schizophrenia
    • Psychotic Disorder
    • Dissociative Disorder
    • Obsessive Compulsive Disorder
    • Dissociative Disorder
    • Attention Deficit Hyperactivity Disorder (ADHD)
    • Other Psychiatric Disorders
  • Behavioral Disorders
    • Self-Harm
    • Aggression
    • Sleep Disorder
    • Social Withdrawal
    • Dissociative Disorder
    • Hyperactivity
    • Other Behavioral Disorders
  • Cognitive Disorders
    • Cognitive Impairment
    • Dementia
    • Alzheimer’s Disease
    • Other Cognitive Disorders

by Screening Method

  • Self-reported Questionnaires & Surveys
    • Beck Depression Inventory (BDI)
    • Generalized Anxiety Disorder-7 (GAD-7)
    • Patient Health Questionnaire-12 (PHQ-12)
    • Hamilton Anxiety Rating Scale (HAM-A)
    • Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
    • Other Self-reported Questionnaires & Surveys
  • Clinical Interviews
    • Structured Clinical Interview for DSM (SCID)
    • Mini International Neuropsychiatric Interview (MINI)
    • Diagnostic Interview for Psychological Distress (DIPD)
    • Other Clinical Interviews
  • Observation-based Assessments
  • Biomarker Testing

by Technology

  • Self-screening mHealth Apps
  • Telehealth & Virtual Care Solutions
  • Continuous Monitoring Wearable Devices
  • AI-based Screening Tools
  • Remote Mental Health Platforms

By Age Group

  • Children & Adolescents (Age 0–18 Years)
  • Adults (Age 19–64)
  • Seniors (Age 65 and above)

By Setting

  • Clinical Settings
  • Educational Institutions
  • Workplace/Corporate Programs
  • Online Platforms
  • Other Settings

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • Rest of the Middle East & Africa

Recent Development of Mental Health Screening Industry:

  • In November 2023, SonderMind (US) acquired Total Brain (US) to expand its reach, offering individualized mental wellness, supporting therapists with enhanced care techniques, providing population mental health tools for enterprises, and delivering comprehensive solutions to health plans.
  • In October 2023, Ellipsis Health, Inc. (US) partnered with Augmedix (US) to introduce automated mental health screenings during patient visits.
  • In December 2021, Quartet Health, Inc. (US) successfully acquired InnovaTel Telepsychiatry (US), turning its vision of rapidly delivering high-quality mental healthcare for everyone into a reality.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 71)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKET SEGMENTATION
                    FIGURE 1 MENTAL HEALTH SCREENING MARKET SEGMENTATION
           1.3.2 REGIONAL SEGMENTATION
                    FIGURE 2 MENTAL HEALTH SCREENING INDUSTRY: REGIONAL SEGMENTATION
           1.3.3 YEARS CONSIDERED
    1.4 STAKEHOLDERS 
    1.5 CURRENCY CONSIDERED 
 
2 RESEARCH METHODOLOGY (Page No. - 76)
    2.1 RESEARCH DATA 
    2.2 RESEARCH APPROACH 
          FIGURE 3 RESEARCH APPROACH
           2.2.1 SECONDARY DATA
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    FIGURE 4 PRIMARY SOURCES
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Key industry insights
                    2.2.2.3 Breakdown of primaries
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION 
          FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 7 MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR KONINKLIJKE PHILIPS
          FIGURE 8 CAGR PROJECTIONS
          FIGURE 9 IMPACT ON MARKET GROWTH AND CAGR: ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2029)
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.5 MARKET SHARE ESTIMATION 
    2.6 STUDY ASSUMPTIONS 
    2.7 LIMITATIONS 
           2.7.1 METHODOLOGY-RELATED LIMITATIONS
           2.7.2 SCOPE-RELATED LIMITATIONS
    2.8 RISK ASSESSMENT 
          TABLE 1 RISK ASSESSMENT: MARKET
    2.9 IMPACT OF RECESSION ON MARKET 
 
3 EXECUTIVE SUMMARY (Page No. - 89)
    FIGURE 11 MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
    FIGURE 12 MENTAL HEALTH SCREENING INDUSTRY, BY SCREENING METHOD, 2023 VS. 2029 (USD MILLION)
    FIGURE 13 MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 MARKET, BY AGE GROUP, 2023 VS. 2029 (USD MILLION)
    FIGURE 15 MARKET, BY SETTING, 2023 VS. 2029 (USD MILLION)
    FIGURE 16 GEOGRAPHICAL SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 94)
    4.1 MENTAL HEALTH SCREENING MARKET OVERVIEW 
          FIGURE 17 GROWING INCIDENCE OF MENTAL HEALTH DISORDERS TO DRIVE MARKET
    4.2 ASIA PACIFIC: MENTAL HEALTH SCREENING INDUSTRY, BY APPLICATION AND COUNTRY (2022) 
          FIGURE 18 PHYSIOLOGICAL DISORDERS ACCOUNTED FOR LARGEST SHARE OF MARKET IN 2022
    4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 MARKET, BY REGION (2020−2027) 
          FIGURE 20 NORTH AMERICA TO CONTINUE TO DOMINATE MARKET DURING FORECAST PERIOD
    4.5 MARKET: DEVELOPED VS. EMERGING ECONOMIES 
          FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 98)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 22 MENTAL HEALTH SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Growing geriatric population and subsequent increase in prevalence of mental disorders
                    5.2.1.2 Rising awareness of mental health issues
                    5.2.1.3 Technological advancements
                    5.2.1.4 Increasing focus on remote monitoring
           5.2.2 RESTRAINTS
                    5.2.2.1 Stigma and limited awareness
                    5.2.2.2 Data privacy concerns
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Integration with wearable technologies
                    5.2.3.2 Rise of social media and its impact on adoption of mental health screening tools
           5.2.4 CHALLENGES
                    5.2.4.1 Concerns regarding accuracy and validity
    5.3 KEY INDUSTRY TRENDS 
           5.3.1 INTEGRATION WITH PRIMARY CARE SETTINGS
           5.3.2 DIGITAL AND REMOTE SOLUTIONS
    5.4 PRICING ANALYSIS 
          TABLE 2 AVERAGE SELLING PRICE TREND, BY REGION
          TABLE 3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY
    5.5 VALUE/SUPPLY CHAIN ANALYSIS 
           5.5.1 RESEARCH & DEVELOPMENT
           5.5.2 MANUFACTURING & PRODUCTION
           5.5.3 DISTRIBUTION
           5.5.4 MARKETING & SALES
           5.5.5 POST-SALES SERVICES
                    FIGURE 23 MENTAL HEALTH SCREENING INDUSTRY: VALUE CHAIN ANALYSIS
    5.6 ECOSYSTEM ANALYSIS 
    5.7 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 4 PORTER’S FIVE FORCES ANALYSIS: MARKET
           5.7.1 INTENSITY OF COMPETITIVE RIVALRY
           5.7.2 BARGAINING POWER OF SUPPLIERS
           5.7.3 BARGAINING POWER OF BUYERS
           5.7.4 THREAT OF NEW ENTRANTS
           5.7.5 THREAT OF SUBSTITUTES
    5.8 REGULATORY LANDSCAPE 
           5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.8.2 REGULATORY ANALYSIS
                    5.8.2.1 North America
                    5.8.2.2 Europe
                    5.8.2.3 Asia Pacific
                    5.8.2.4 Latin America
                    5.8.2.5 Middle East & Africa
    5.9 TECHNOLOGY ANALYSIS 
           5.9.1 KEY TECHNOLOGIES
                    5.9.1.1 Artificial Intelligence (AI) & Machine Learning (ML)
                    5.9.1.2 Telehealth platforms
                    5.9.1.3 Mobile apps and platforms
           5.9.2 COMPLEMENTARY TECHNOLOGIES
                    5.9.2.1 Electronic Health Records (EHRs)
                    5.9.2.2 Chatbots and virtual assistants
           5.9.3 ADJACENT TECHNOLOGIES
                    5.9.3.1 Genetic and biological markers
    5.10 PATENT ANALYSIS 
           5.10.1 PATENT PUBLICATION TRENDS FOR MENTAL HEALTH SCREENING
           5.10.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES
                     FIGURE 24 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR MENTAL HEALTH SCREENING PATENTS, 2012–2023
           5.10.3 MAJOR PATENTS IN MARKET
                     FIGURE 25 MAJOR PATENTS FOR MENTAL HEALTH SCREENING SOLUTIONS (2012–2023)
           5.10.4 PATENTS FILED
    5.11 TRADE ANALYSIS 
           FIGURE 26 PRODUCT EXPORTS UNDER HSN CODE: 9113, BY COUNTRY, 2022 (USD THOUSAND)
           FIGURE 27 PRODUCT IMPORTS UNDER HSN CODE 9113, BY COUNTRY, 2022 (USD THOUSAND)
    5.12 CASE STUDY ANALYSIS 
           TABLE 6 CASE STUDY 1: AIBERRY'S COLLABORATIVE CLINICAL STUDY WITH UNIVERSITY OF ARIZONA FOR AI-POWERED MENTAL HEALTH SCREENING PLATFORM
           TABLE 7 CASE STUDY 2: IMPACT OF MINDWISE SCREENING PROGRAM AT HARVARD UNIVERSITY
    5.13 KEY CONFERENCES & EVENTS, 2024–2025 
           5.13.1 LIST OF KEY CONFERENCES & EVENTS IN MARKET, 2024–2025
    5.14 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                      TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MENTAL HEALTH SCREENING SOLUTIONS
                      TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS IN MARKET, BY TECHNOLOGY
           5.14.2 BUYING CRITERIA
                      FIGURE 28 KEY BUYING CRITERIA FOR MENTAL HEALTH SCREENING SOLUTIONS, BY TECHNOLOGY
                      TABLE 10 KEY BUYING CRITERIA FOR MENTAL HEALTH SCREENING SOLUTIONS, BY TECHNOLOGY
    5.15 UNMET NEEDS 
           TABLE 11 UNMET NEEDS IN MARKET
           5.15.1 END-USER EXPECTATIONS
                      TABLE 12 END-USER EXPECTATIONS IN MARKET
    5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
           FIGURE 29 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR MARKET
    5.17 REIMBURSEMENT SCENARIO ANALYSIS 
           TABLE 13 CPT CODES AND REIMBURSEMENT ANALYSIS IN MARKET IN US
    5.18 BUSINESS MODEL ANALYSIS 
    5.19 INVESTMENT & FUNDING SCENARIO 
           FIGURE 30 INVESTOR DEALS AND VC FUNDING OF US-BASED MENTAL HEALTH STARTUPS INCREASED IN 2020
 
6 MENTAL HEALTH SCREENING MARKET, BY APPLICATION (Page No. - 131)
    6.1 INTRODUCTION 
          TABLE 14 MENTAL HEALTH SCREENING INDUSTRY, BY APPLICATION, 2018–2021 (USD MILLION)
          TABLE 15 MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
    6.2 PHYSIOLOGICAL DISORDERS 
          TABLE 16 MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
          TABLE 17 MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 18 MARKET FOR PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)
          TABLE 19 MARKET FOR PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.1 DEPRESSION
                    6.2.1.1 Increased adoption of depression screening to drive market
                                TABLE 20 MARKET FOR DEPRESSION, BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 21 MARKET FOR DEPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.2 ANXIETY
                    6.2.2.1 Increasing burden of anxiety disorders & rising awareness to fuel market growth
                                TABLE 22 MARKET FOR ANXIETY, BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 23 MARKET FOR ANXIETY, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.3 POST-TRAUMATIC STRESS DISORDER (PTSD)
                    6.2.3.1 Rising number of initiatives for PTSD to propel market
                                TABLE 24 MARKET FOR POST-TRAUMATIC STRESS DISORDER (PTSD), BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 25 MARKET FOR POST-TRAUMATIC STRESS DISORDER (PTSD), BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.4 BIPOLAR DISORDER
                    6.2.4.1 Growing public awareness to drive bipolar disorder screening uptake
                                TABLE 26 MARKET FOR BIPOLAR DISORDER, BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 27 MARKET FOR BIPOLAR DISORDER, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.5 EATING DISORDER
                    6.2.5.1 Increasing incidence and hospital visits to drive adoption of eating disorder screening
                                FIGURE 31 GLOBAL EATING DISORDER PREVALENCE, BY AGE, 2015–2019
                                TABLE 28 MENTAL HEALTH SCREENING MARKET FOR EATING DISORDER, BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 29 MARKET FOR EATING DISORDER, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.6 SUBSTANCE USE
                    6.2.6.1 Increasing cases of substance use to drive market
                                TABLE 30 MARKET FOR SUBSTANCE USE, BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 31 MARKET FOR SUBSTANCE USE, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.7 OTHER PHYSIOLOGICAL DISORDERS
                    TABLE 32 MARKET FOR OTHER PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 33 MARKET FOR OTHER PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)
    6.3 PSYCHIATRIC DISORDERS 
          TABLE 34 MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
          TABLE 35 MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 36 MARKET FOR PSYCHIATRIC DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)
          TABLE 37 MARKET FOR PSYCHIATRIC DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.1 SCHIZOPHRENIA
                    6.3.1.1 Advancements in screening tools for schizophrenia to support growth
                                TABLE 38 MARKET FOR SCHIZOPHRENIA, BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 39 MARKET FOR SCHIZOPHRENIA, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.2 PSYCHOTIC DISORDER
                    6.3.2.1 Increasing need for screening tools for early detection to drive market growth
                                TABLE 40 MARKET FOR PSYCHOTIC DISORDER, BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 41 MARKET FOR PSYCHOTIC DISORDER, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.3 DISSOCIATIVE DISORDER
                    6.3.3.1 Growing awareness and education through screening and content creation to favor market growth
                                TABLE 42 MARKET FOR DISSOCIATIVE DISORDER, BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 43 MARKET FOR DISSOCIATIVE DISORDER, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.4 OBSESSIVE COMPULSIVE DISORDER (OCD)
                    6.3.4.1 Advancements in assessment tools to support market growth
                                TABLE 44 MARKET FOR OBSESSIVE COMPULSIVE DISORDER (OCD), BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 45 MARKET FOR OBSESSIVE COMPULSIVE DISORDER (OCD), BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.5 ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
                    6.3.5.1 Increasing cases & diagnosis to contribute to increased demand for ADHD screening
                                TABLE 46 MENTAL HEALTH SCREENING MARKET FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 47 MARKET FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.6 OTHER PSYCHIATRIC DISORDERS
                    TABLE 48 MARKET FOR OTHER PSYCHIATRIC DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 49 MARKET FOR OTHER PSYCHIATRIC DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)
    6.4 BEHAVIORAL DISORDERS 
          TABLE 50 MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
          TABLE 51 MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 52 MARKET FOR BEHAVIORAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)
          TABLE 53 MARKET FOR BEHAVIORAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)
           6.4.1 SELF-HARM
                    6.3.1.1 Advancements in screening tools for schizophrenia to support growth
                                TABLE 38 MARKET FOR SCHIZOPHRENIA, BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 39 MARKET FOR SCHIZOPHRENIA, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.2 PSYCHOTIC DISORDER
                    6.3.2.1 Increasing need for screening tools for early detection to drive market growth
                                TABLE 40 MARKET FOR PSYCHOTIC DISORDER, BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 41 MARKET FOR PSYCHOTIC DISORDER, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.3 DISSOCIATIVE DISORDER
                    6.3.3.1 Growing awareness and education through screening and content creation to favor market growth
                                TABLE 42 MARKET FOR DISSOCIATIVE DISORDER, BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 43 MARKET FOR DISSOCIATIVE DISORDER, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.4 OBSESSIVE COMPULSIVE DISORDER (OCD)
                    6.3.4.1 Advancements in assessment tools to support market growth
                                TABLE 44 MARKET FOR OBSESSIVE COMPULSIVE DISORDER (OCD), BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 45 MARKET FOR OBSESSIVE COMPULSIVE DISORDER (OCD), BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.5 ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
                    6.3.5.1 Increasing cases & diagnosis to contribute to increased demand for ADHD screening
                                TABLE 46 MARKET FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 47 MARKET FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.6 OTHER PSYCHIATRIC DISORDERS
                    TABLE 64 MENTAL HEALTH SCREENING MARKET FOR OTHER BEHAVIORAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 65 MARKET FOR OTHER BEHAVIORAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)
    6.5 COGNITIVE DISORDERS 
          TABLE 66 MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
          TABLE 67 MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 68 MARKET FOR COGNITIVE DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)
          TABLE 69 MARKET FOR COGNITIVE DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)
           6.5.1 COGNITIVE IMPAIRMENT
                    6.5.1.1 Growing geriatric population and rising incidence of neurodegenerative disorders to support market growth
                                TABLE 70 MARKET FOR COGNITIVE IMPAIRMENT, BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 71 MARKET FOR COGNITIVE IMPAIRMENT, BY COUNTRY, 2022–2029 (USD MILLION)
           6.5.2 DEMENTIA
                    6.5.2.1 Rising initiatives to promote dementia screening awareness to fuel market
                                TABLE 72 MARKET FOR DEMENTIA, BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 73 MARKET FOR DEMENTIA FOR, BY COUNTRY, 2022–2029 (USD MILLION)
           6.5.3 ALZHEIMER’S DISEASE
                    6.5.3.1 Favorable initiatives and increased access to screening to drive market
                                TABLE 74 MARKET FOR ALZHEIMER’S DISEASE, BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 75 MARKET FOR ALZHEIMER’S DISEASE, BY COUNTRY, 2022–2029 (USD MILLION)
           6.5.4 OTHER COGNITIVE DISORDERS
                    TABLE 76 MARKET FOR OTHER COGNITIVE DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 77 MARKET FOR OTHER COGNITIVE DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)
 
7 MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD (Page No. - 186)
    7.1 INTRODUCTION 
          TABLE 78 MENTAL HEALTH SCREENING INDUSTRY, BY SCREENING METHOD, 2018–2021 (USD MILLION)
          TABLE 79 MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
    7.2 SELF-REPORTED QUESTIONNAIRES & SURVEYS 
          TABLE 80 MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
          TABLE 81 MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 82 MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2018–2021 (USD MILLION)
          TABLE 83 MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2022–2029 (USD MILLION)
           7.2.1 BECK DEPRESSION INVENTORY (BDI)
                    7.2.1.1 Increasing prevalence of depression to drive demand for BDI
                                TABLE 84 MARKET FOR BECK DEPRESSION INVENTORY (BDI), BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 85 MARKET FOR BECK DEPRESSION INVENTORY (BDI), BY COUNTRY, 2022–2029 (USD MILLION)
           7.2.2 GENERALIZED ANXIETY DISORDER-7 (GAD-7)
                    7.2.2.1 Growing concerns regarding anxiety disorders in adults to boost market
                                TABLE 86 MARKET FOR GENERALIZED ANXIETY DISORDER-7 (GAD-7), BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 87 MENTAL HEALTH SCREENING MARKET FOR GENERALIZED ANXIETY DISORDER-7 (GAD-7), BY COUNTRY, 2022–2029 (USD MILLION)
           7.2.3 HAMILTON ANXIETY RATING SCALE (HAM-A)
                    7.2.3.1 Increasing demand for standardized & reliable assessment tools to favor market growth
                                TABLE 88 MARKET FOR HAMILTON ANXIETY RATING SCALE (HAM-A), BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 89 MARKET FOR HAMILTON ANXIETY RATING SCALE (HAM-A), BY COUNTRY, 2022–2029 (USD MILLION)
           7.2.4 PATIENT HEALTH QUESTIONNAIRE-12 (PHQ-12)
                    7.2.4.1 Growing focus on early intervention to boost demand
                                TABLE 90 MARKET FOR PATIENT HEALTH QUESTIONNAIRE-12 (PHQ-12), BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 91 MARKET FOR PATIENT HEALTH QUESTIONNAIRE-12 (PHQ-12), BY COUNTRY, 2022–2029 (USD MILLION)
           7.2.5 YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS)
                    7.2.5.1 Rising awareness of obsessive compulsive disorder (OCD) to fuel growth
                                TABLE 92 MARKET FOR YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS), BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 93 MARKET FOR YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS), BY COUNTRY, 2022–2029 (USD MILLION)
           7.2.6 OTHER SELF-REPORTED QUESTIONNAIRES & SURVEYS
                    TABLE 94 MARKET FOR OTHER SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 95 MARKET FOR OTHER SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2022–2029 (USD MILLION)
    7.3 CLINICAL INTERVIEWS 
          TABLE 96 MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
          TABLE 97 MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 98 MARKET FOR CLINICAL INTERVIEWS, BY COUNTRY, 2018–2021 (USD MILLION)
          TABLE 99 MARKET FOR CLINICAL INTERVIEWS, BY COUNTRY, 2022–2029 (USD MILLION)
           7.3.1 MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI)
                    7.3.1.1 Increasing global burden of psychiatric disorders to boost market growth
                                TABLE 100 MENTAL HEALTH SCREENING MARKET FOR MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI), BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 101 MARKET FOR MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI), BY COUNTRY, 2022–2029 (USD MILLION)
           7.3.2 STRUCTURED CLINICAL INTERVIEWS FOR DSM (SCID)
                    7.3.2.1 Growing demand for comprehensive & detail assessment screening methods to favor market growth
                                TABLE 102 MARKET FOR STRUCTURED CLINICAL INTERVIEWS FOR DSM (SCID), BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 103 MARKET FOR STRUCTURED CLINICAL INTERVIEWS FOR DSM (SCID), BY COUNTRY, 2022–2029 (USD MILLION)
           7.3.3 DIAGNOSTIC INTERVIEW FOR PSYCHOLOGICAL DISTRESS (DIPD)
                    7.3.3.1 Increasing prevalence of psychological distress post pandemic to drive demand for DIPD
                                TABLE 104 MARKET FOR DIAGNOSTIC INTERVIEW FOR PSYCHOLOGICAL DISTRESS (DIPD), BY COUNTRY, 2018–2021 (USD MILLION)
                                TABLE 105 MARKET FOR DIAGNOSTIC INTERVIEW FOR PSYCHOLOGICAL DISTRESS (DIPD), BY COUNTRY, 2022–2029 (USD MILLION)
           7.3.4 OTHER CLINICAL INTERVIEWS
                    TABLE 106 MARKET FOR OTHER CLINICAL INTERVIEWS, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 107 MARKET FOR OTHER CLINICAL INTERVIEWS, BY COUNTRY, 2022–2029 (USD MILLION)
    7.4 OBSERVATION-BASED ASSESSMENTS 
           7.4.1 ADVANCES IN WEARABLE TECHNOLOGIES TO REVOLUTIONIZE OBSERVATION-BASED ASSESSMENT TOOLS
                    TABLE 108 MARKET FOR OBSERVATION-BASED ASSESSMENTS, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 109 MARKET FOR OBSERVATION-BASED ASSESSMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
    7.5 BIOMARKER TESTING 
           7.5.1 ADVANCES IN ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING TO DRIVE ADOPTION OF BIOMARKER TESTING TECHNOLOGIES
                    TABLE 110 MARKET FOR BIOMARKER TESTING, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 111 MARKET FOR BIOMARKER TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
 
8 MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY (Page No. - 218)
    8.1 INTRODUCTION 
          TABLE 112 MENTAL HEALTH SCREENING INDUSTRY, BY TECHNOLOGY, 2018–2021 (USD MILLION)
          TABLE 113 MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
    8.2 SELF-SCREENING MHEALTH APPS 
           8.2.1 INCREASING AWARENESS AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE ADOPTION OF MHEALTH APPS IN FUTURE
                    TABLE 114 MARKET FOR SELF-SCREENING MHEALTH APPS, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 115 MARKET FOR SELF-SCREENING MHEALTH APPS, BY COUNTRY, 2022–2029 (USD MILLION)
    8.3 TELEHEALTH & VIRTUAL CARE SOLUTIONS 
           8.3.1 RISING DEMAND FOR ACCESSIBLE AND CONVENIENT HEALTHCARE SERVICES TO FUEL MARKET GROWTH
                    TABLE 116 MARKET FOR TELEHEALTH & VIRTUAL CARE SOLUTIONS, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 117 MENTAL HEALTH SCREENING MARKET FOR TELEHEALTH & VIRTUAL CARE SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
    8.4 CONTINUOUS MONITORING WEARABLE DEVICES 
           8.4.1 SHIFT TOWARDS PROACTIVE AND PERSONALIZED HEALTHCARE TO DRIVE MARKET GROWTH
                    TABLE 118 MARKET FOR CONTINUOUS MONITORING WEARABLE DEVICES, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 119 MARKET FOR CONTINUOUS MONITORING WEARABLE DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
    8.5 AI-BASED SCREENING TOOLS 
           8.5.1 HIGH COST ASSOCIATED WITH AI-BASED SCREENING TOOLS TO RESTRAIN MARKET GROWTH
                    TABLE 120 MARKET FOR AI-BASED SCREENING TOOLS, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 121 MARKET FOR AI-BASED SCREENING TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
    8.6 REMOTE MENTAL HEALTH PLATFORMS 
           8.6.1 INCREASED ADOPTION OF REMOTE MENTAL HEALTH SCREENING PLATFORMS TO FAVOR MARKET GROWTH
                    TABLE 122 MARKET FOR REMOTE MENTAL HEALTH PLATFORMS, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 123 MARKET FOR REMOTE MENTAL HEALTH PLATFORMS, BY COUNTRY, 2022–2029 (USD MILLION)
 
9 MENTAL HEALTH SCREENING MARKET, BY AGE GROUP (Page No. - 231)
    9.1 INTRODUCTION 
          TABLE 124 MENTAL HEALTH SCREENING INDUSTRY, BY AGE GROUP, 2018–2021 (USD MILLION)
          TABLE 125 MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
    9.2 CHILDREN & ADOLESCENTS (AGE 0–18 YEARS) 
           9.2.1 GROWING PREVALENCE OF MENTAL HEALTH DISORDERS IN CHILDREN & ADOLESCENTS TO DRIVE MARKET GROWTH
                    TABLE 126 MARKET FOR CHILDREN & ADOLESCENTS (0–18 YEARS), BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 127 MARKET FOR CHILDREN & ADOLESCENTS (0–18 YEARS), BY COUNTRY, 2022–2029 (USD MILLION)
    9.3 ADULTS (AGE 19–64 YEARS) 
           9.3.1 GROWING POPULARITY OF WORKPLACE WELLNESS PROGRAMS TO BOOST DEMAND FOR MENTAL HEALTH SCREENING
                    TABLE 128 MARKET FOR ADULTS (AGE 19–64 YEARS), BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 129 MARKET FOR ADULTS (AGE 19–64 YEARS), BY COUNTRY, 2022–2029 (USD MILLION)
    9.4 SENIORS (AGE 65 AND ABOVE) 
           9.4.1 GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN AGE-RELATED MENTAL DISORDERS TO BOOST MARKET
                    TABLE 130 MARKET FOR SENIORS (AGE 65 AND ABOVE), BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 131 MARKET FOR SENIORS (AGE 65 AND ABOVE), BY COUNTRY, 2022–2029 (USD MILLION)
 
10 MENTAL HEALTH SCREENING MARKET, BY SETTING (Page No. - 240)
     10.1 INTRODUCTION 
             TABLE 132 MENTAL HEALTH SCREENING INDUSTRY, BY SETTING, 2018–2021 (USD MILLION)
             TABLE 133 MARKET, BY SETTING, 2022–2029 (USD MILLION)
     10.2 CLINICAL SETTINGS 
             10.2.1 SHIFT TOWARDS PREVENTIVE AND PATIENT-CENTRED CARE TO DRIVE MARKET GROWTH
                        TABLE 134 MARKET FOR CLINICAL SETTINGS, BY COUNTRY, 2018–2021 (USD MILLION)
                        TABLE 135 MARKET FOR CLINICAL SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
     10.3 EDUCATIONAL INSTITUTIONS 
             10.3.1 GROWING INITIATIVES TO BOOST GROWTH
                        TABLE 136 MARKET FOR EDUCATIONAL INSTITUTIONS, BY COUNTRY, 2018–2021 (USD MILLION)
                        TABLE 137 MENTAL HEALTH SCREENING MARKET FOR EDUCATIONAL INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
     10.4 WORKPLACE/CORPORATE PROGRAMS 
             10.4.1 RISING MENTAL HEALTH CHALLENGES AND DUTY OF CARE TO DRIVE MARKET GROWTH
                        TABLE 138 MARKET FOR WORKPLACE/CORPORATE PROGRAMS, BY COUNTRY, 2018–2021 (USD MILLION)
                        TABLE 139 MARKET FOR WORKPLACE/CORPORATE PROGRAMS, BY COUNTRY, 2022–2029 (USD MILLION)
     10.5 ONLINE PLATFORMS 
             10.5.1 ACCESSIBLE AND PERSONALIZED ASSESSMENTS TO DRIVE DEMAND
                        TABLE 140 MARKET FOR ONLINE PLATFORMS, BY COUNTRY, 2018–2021 (USD MILLION)
                        TABLE 141 MARKET FOR ONLINE PLATFORMS, BY COUNTRY, 2022–2029 (USD MILLION)
     10.6 OTHER SETTINGS 
             TABLE 142 MARKET FOR OTHER SETTINGS, BY COUNTRY, 2018–2021 (USD MILLION)
             TABLE 143 MARKET FOR OTHER SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
 
11 MENTAL HEALTH SCREENING MARKET, BY REGION (Page No. - 252)
     11.1 INTRODUCTION 
             TABLE 144 MENTAL HEALTH SCREENING INDUSTRY, BY REGION, 2018–2021 (USD MILLION)
             TABLE 145 MENTAL HEALTH SCREENING INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
     11.2 NORTH AMERICA 
             FIGURE 32 NORTH AMERICA: MARKET SNAPSHOT
             TABLE 146 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
             TABLE 147 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
             TABLE 148 NORTH AMERICA: MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
             TABLE 149 NORTH AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
             TABLE 150 NORTH AMERICA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 151 NORTH AMERICA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 152 NORTH AMERICA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 153 NORTH AMERICA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 154 NORTH AMERICA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 155 NORTH AMERICA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 156 NORTH AMERICA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 157 NORTH AMERICA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 158 NORTH AMERICA: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
             TABLE 159 NORTH AMERICA: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
             TABLE 160 NORTH AMERICA: SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 161 NORTH AMERICA: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 162 NORTH AMERICA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 163 NORTH AMERICA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 164 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
             TABLE 165 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
             TABLE 166 NORTH AMERICA: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
             TABLE 167 NORTH AMERICA: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
             TABLE 168 NORTH AMERICA: MARKET, BY SETTING, 2018–2021 (USD MILLION)
             TABLE 169 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
             11.2.1 NORTH AMERICA: RECESSION IMPACT
             11.2.2 US
                        11.2.2.1 US to dominate North American market
                                      TABLE 170 US: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
                                      TABLE 171 US: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 172 US: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 173 US: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 174 US: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 175 US: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 176 US: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 177 US: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 178 US: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 179 US: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 180 US: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
                                      TABLE 181 US: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
                                      TABLE 182 US: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 183 US: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 184 US: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 185 US: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 186 US: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
                                      TABLE 187 US: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 188 US: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
                                      TABLE 189 US: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
                                      TABLE 190 US: MARKET, BY SETTING, 2018–2021 (USD MILLION)
                                      TABLE 191 US: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
             11.2.3 CANADA
                        11.2.3.1 Growing investments in mental health and well-being to contribute to market growth
                                      TABLE 192 CANADA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
                                      TABLE 193 CANADA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 194 CANADA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 195 CANADA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 196 CANADA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 197 CANADA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 198 CANADA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 199 CANADA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 200 CANADA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 201 CANADA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 202 CANADA: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
                                      TABLE 203 CANADA: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
                                      TABLE 204 CANADA: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 205 CANADA: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 206 CANADA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 207 CANADA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 208 CANADA: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
                                      TABLE 209 CANADA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 210 CANADA: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
                                      TABLE 211 CANADA: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
                                      TABLE 212 CANADA: MARKET, BY SETTING, 2018–2021 (USD MILLION)
                                      TABLE 213 CANADA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
     11.3 EUROPE 
             TABLE 214 EUROPE: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
             TABLE 215 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
             TABLE 216 EUROPE: MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
             TABLE 217 EUROPE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
             TABLE 218 EUROPE: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 219 EUROPE: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 220 EUROPE: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 221 EUROPE: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 222 EUROPE: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 223 EUROPE: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 224 EUROPE: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 225 EUROPE: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 226 EUROPE: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
             TABLE 227 EUROPE: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
             TABLE 228 EUROPE: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 229 EUROPE: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 230 EUROPE: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 231 EUROPE: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 232 EUROPE: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
             TABLE 233 EUROPE: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
             TABLE 234 EUROPE: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
             TABLE 235 EUROPE: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
             TABLE 236 EUROPE: MARKET, BY SETTING, 2018–2021 (USD MILLION)
             TABLE 237 EUROPE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
             11.3.1 EUROPE: RECESSION IMPACT
             11.3.2 UK
                        11.3.2.1 Long waiting periods and inadequate access to care to favor market growth
                                      TABLE 238 UK: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
                                      TABLE 239 UK: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 240 UK: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 241 UK: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 242 UK: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 243 UK: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 244 UK: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 245 UK: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 246 UK: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 247 UK: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 248 UK: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
                                      TABLE 249 UK: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
                                      TABLE 250 UK: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 251 UK: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 252 UK: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 253 UK: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 254 UK: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
                                      TABLE 255 UK: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 256 UK: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
                                      TABLE 257 UK: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
                                      TABLE 258 UK: MARKET, BY SETTING, 2018–2021 (USD MILLION)
                                      TABLE 259 UK: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
             11.3.3 GERMANY
                        11.3.3.1 Large patient base and growing burden on health providers to drive demand for HCIT solutions
                                      TABLE 260 GERMANY: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
                                      TABLE 261 GERMANY: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 262 GERMANY: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 263 GERMANY: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 264 GERMANY: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 265 GERMANY: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 266 GERMANY: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 267 GERMANY: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 268 GERMANY: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 269 GERMANY: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 270 GERMANY: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
                                      TABLE 271 GERMANY: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
                                      TABLE 272 GERMANY: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 273 GERMANY: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 274 GERMANY: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 275 GERMANY: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 276 GERMANY: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
                                      TABLE 277 GERMANY: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 278 GERMANY: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
                                      TABLE 279 GERMANY: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
                                      TABLE 280 GERMANY: MARKET, BY SETTING, 2018–2021 (USD MILLION)
                                      TABLE 281 GERMANY: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
             11.3.4 FRANCE
                        11.3.4.1 High prevalence of behavioral disorders to drive support for implementing mental health screening solutions in France
                                      TABLE 282 FRANCE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
                                      TABLE 283 FRANCE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 284 FRANCE: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 285 FRANCE: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 286 FRANCE: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 287 FRANCE: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 288 FRANCE: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 289 FRANCE: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 290 FRANCE: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 291 FRANCE: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 292 FRANCE: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
                                      TABLE 293 FRANCE: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
                                      TABLE 294 FRANCE: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 295 FRANCE: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 296 FRANCE: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 297 FRANCE: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 298 FRANCE: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
                                      TABLE 299 FRANCE: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 300 FRANCE: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
                                      TABLE 301 FRANCE: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
                                      TABLE 302 FRANCE: MARKET, BY SETTING, 2018–2021 (USD MILLION)
                                      TABLE 303 FRANCE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
             11.3.5 REST OF EUROPE
                        TABLE 304 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
                        TABLE 305 REST OF EUROPE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 306 REST OF EUROPE: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 307 REST OF EUROPE: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 308 REST OF EUROPE: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 309 REST OF EUROPE: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 310 REST OF EUROPE: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 311 REST OF EUROPE: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 312 REST OF EUROPE: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 313 REST OF EUROPE: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 314 REST OF EUROPE: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
                        TABLE 315 REST OF EUROPE: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
                        TABLE 316 REST OF EUROPE: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 317 REST OF EUROPE: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 318 REST OF EUROPE: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 319 REST OF EUROPE: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 320 REST OF EUROPE: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
                        TABLE 321 REST OF EUROPE: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 322 REST OF EUROPE: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
                        TABLE 323 REST OF EUROPE: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
                        TABLE 324 REST OF EUROPE: MARKET, BY SETTING, 2018–2021 (USD MILLION)
                        TABLE 325 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
     11.4 ASIA PACIFIC 
             FIGURE 33 ASIA PACIFIC: MARKET SNAPSHOT
             TABLE 326 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
             TABLE 327 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
             TABLE 328 ASIA PACIFIC: MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
             TABLE 329 ASIA PACIFIC: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
             TABLE 330 ASIA PACIFIC: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 331 ASIA PACIFIC: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 332 ASIA PACIFIC: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 333 ASIA PACIFIC: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 334 ASIA PACIFIC: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 335 ASIA PACIFIC: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 336 ASIA PACIFIC: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 337 ASIA PACIFIC: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 338 ASIA PACIFIC: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
             TABLE 339 ASIA PACIFIC: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
             TABLE 340 ASIA PACIFIC: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 341 ASIA PACIFIC: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 342 ASIA PACIFIC: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 343 ASIA PACIFIC: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 344 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
             TABLE 345 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
             TABLE 346 ASIA PACIFIC: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
             TABLE 347 ASIA PACIFIC: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
             TABLE 348 ASIA PACIFIC: MARKET, BY SETTING, 2018–2021 (USD MILLION)
             TABLE 349 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
             11.4.1 ASIA PACIFIC: RECESSION IMPACT
             11.4.2 CHINA
                        11.4.2.1 Rising incidence of mental illnesses to drive demand for care solutions in China
                                      TABLE 350 CHINA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
                                      TABLE 351 CHINA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 352 CHINA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 353 CHINA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 354 CHINA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 355 CHINA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 356 CHINA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 357 CHINA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 358 CHINA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 359 CHINA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 360 CHINA: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
                                      TABLE 361 CHINA: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
                                      TABLE 362 CHINA: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 363 CHINA: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 364 CHINA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 365 CHINA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 366 CHINA: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
                                      TABLE 367 CHINA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 368 CHINA: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
                                      TABLE 369 CHINA: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
                                      TABLE 370 CHINA: MARKET, BY SETTING, 2018–2021 (USD MILLION)
                                      TABLE 371 CHINA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
             11.4.3 JAPAN
                        11.4.3.1 Rising geriatric population in Japan and subsequent increase in age-related mental disorders to boost market
                                      TABLE 372 JAPAN: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
                                      TABLE 373 JAPAN: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 374 JAPAN: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 375 JAPAN: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 376 JAPAN: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 377 JAPAN: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 378 JAPAN: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 379 JAPAN: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 380 JAPAN: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 381 JAPAN: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 382 JAPAN: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
                                      TABLE 383 JAPAN: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
                                      TABLE 384 JAPAN: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 385 JAPAN: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 386 JAPAN: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 387 JAPAN: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 388 JAPAN: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
                                      TABLE 389 JAPAN: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 390 JAPAN: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
                                      TABLE 391 JAPAN: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
                                      TABLE 392 JAPAN: MARKET, BY SETTING, 2018–2021 (USD MILLION)
                                      TABLE 393 JAPAN: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
             11.4.4 INDIA
                        11.4.4.1 Inadequate workforce and lack of access to drive adoption of solutions
                                      TABLE 394 INDIA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
                                      TABLE 395 INDIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 396 INDIA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 397 INDIA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 398 INDIA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 399 INDIA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 400 INDIA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 401 INDIA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 402 INDIA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 403 INDIA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 404 INDIA: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
                                      TABLE 405 INDIA: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
                                      TABLE 406 INDIA: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 407 INDIA: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 408 INDIA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 409 INDIA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 410 INDIA: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
                                      TABLE 411 INDIA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 412 INDIA: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
                                      TABLE 413 INDIA: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
                                      TABLE 414 INDIA: MARKET, BY SETTING, 2018–2021 (USD MILLION)
                                      TABLE 415 INDIA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
             11.4.5 REST OF ASIA PACIFIC
                        TABLE 416 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
                        TABLE 417 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 418 REST OF ASIA PACIFIC: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 419 REST OF ASIA PACIFIC: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 420 REST OF ASIA PACIFIC: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 421 REST OF ASIA PACIFIC: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 422 REST OF ASIA PACIFIC: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 423 REST OF ASIA PACIFIC: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 424 REST OF ASIA PACIFIC: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 425 REST OF ASIA PACIFIC: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 426 REST OF ASIA PACIFIC: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
                        TABLE 427 REST OF ASIA PACIFIC: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
                        TABLE 428 REST OF ASIA PACIFIC: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 429 REST OF ASIA PACIFIC: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 430 REST OF ASIA PACIFIC: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 431 REST OF ASIA PACIFIC: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 432 REST OF ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
                        TABLE 433 REST OF ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 434 REST OF ASIA PACIFIC: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
                        TABLE 435 REST OF ASIA PACIFIC: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
                        TABLE 436 REST OF ASIA PACIFIC: MARKET, BY SETTING, 2018–2021 (USD MILLION)
                        TABLE 437 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
     11.5 LATIN AMERICA 
             TABLE 438 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
             TABLE 439 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
             TABLE 440 LATIN AMERICA: MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
             TABLE 441 LATIN AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
             TABLE 442 LATIN AMERICA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 443 LATIN AMERICA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 444 LATIN AMERICA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 445 LATIN AMERICA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 446 LATIN AMERICA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 447 LATIN AMERICA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 448 LATIN AMERICA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 449 LATIN AMERICA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 450 LATIN AMERICA: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
             TABLE 451 LATIN AMERICA: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
             TABLE 452 LATIN AMERICA: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 453 LATIN AMERICA: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 454 LATIN AMERICA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 455 LATIN AMERICA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 456 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
             TABLE 457 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
             TABLE 458 LATIN AMERICA: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
             TABLE 459 LATIN AMERICA: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
             TABLE 460 LATIN AMERICA: MARKET, BY SETTING, 2018–2021 (USD MILLION)
             TABLE 461 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
             11.5.1 LATIN AMERICA: RECESSION IMPACT
             11.5.2 BRAZIL
                        11.5.2.1 Large healthcare industry and increased investments in healthcare to boost market
                                      TABLE 462 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
                                      TABLE 463 BRAZIL: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 464 BRAZIL: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 465 BRAZIL: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 466 BRAZIL: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 467 BRAZIL: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 468 BRAZIL: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 469 BRAZIL: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 470 BRAZIL: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 471 BRAZIL: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 472 BRAZIL: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
                                      TABLE 473 BRAZIL: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
                                      TABLE 474 BRAZIL: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 475 BRAZIL: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 476 BRAZIL: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 477 BRAZIL: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 478 BRAZIL: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
                                      TABLE 479 BRAZIL: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 480 BRAZIL: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
                                      TABLE 481 BRAZIL: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
                                      TABLE 482 BRAZIL: MARKET, BY SETTING, 2018–2021 (USD MILLION)
                                      TABLE 483 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
             11.5.3 MEXICO
                        11.5.3.1 Growing number of mental health patients to drive market
                                      TABLE 484 MEXICO: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
                                      TABLE 485 MEXICO: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 486 MEXICO: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 487 MEXICO: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 488 MEXICO: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 489 MEXICO: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 490 MEXICO: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 491 MEXICO: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 492 MEXICO: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 493 MEXICO: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 494 MEXICO: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
                                      TABLE 495 MEXICO: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
                                      TABLE 496 MEXICO: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 497 MEXICO: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 498 MEXICO: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 499 MEXICO: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 500 MEXICO: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
                                      TABLE 501 MEXICO: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 502 MEXICO: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
                                      TABLE 503 MEXICO: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
                                      TABLE 504 MEXICO: MARKET, BY SETTING, 2018–2021 (USD MILLION)
                                      TABLE 505 MEXICO: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
             11.5.4 REST OF LATIN AMERICA
                        TABLE 506 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
                        TABLE 507 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 508 REST OF LATIN AMERICA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 509 REST OF LATIN AMERICA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 510 REST OF LATIN AMERICA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 511 REST OF LATIN AMERICA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 512 REST OF LATIN AMERICA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 513 REST OF LATIN AMERICA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 514 REST OF LATIN AMERICA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 515 REST OF LATIN AMERICA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 516 REST OF LATIN AMERICA: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
                        TABLE 517 REST OF LATIN AMERICA: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
                        TABLE 518 REST OF LATIN AMERICA: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 519 REST OF LATIN AMERICA: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 520 REST OF LATIN AMERICA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 521 REST OF LATIN AMERICA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 522 REST OF LATIN AMERICA: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
                        TABLE 523 REST OF LATIN AMERICA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 524 REST OF LATIN AMERICA: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
                        TABLE 525 REST OF LATIN AMERICA: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
                        TABLE 526 REST OF LATIN AMERICA: MARKET, BY SETTING, 2018–2021 (USD MILLION)
                        TABLE 527 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
     11.6 MIDDLE EAST & AFRICA 
             TABLE 528 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
             TABLE 529 MIDDLE EAST & AFRICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
             TABLE 530 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
             TABLE 531 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
             TABLE 532 MIDDLE EAST & AFRICA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 533 MIDDLE EAST & AFRICA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 534 MIDDLE EAST & AFRICA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 535 MIDDLE EAST & AFRICA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 536 MIDDLE EAST & AFRICA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 537 MIDDLE EAST & AFRICA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 538 MIDDLE EAST & AFRICA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 539 MIDDLE EAST & AFRICA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 540 MIDDLE EAST & AFRICA: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
             TABLE 541 MIDDLE EAST & AFRICA: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
             TABLE 542 MIDDLE EAST & AFRICA: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 543 MIDDLE EAST & AFRICA: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 544 MIDDLE EAST & AFRICA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
             TABLE 545 MIDDLE EAST & AFRICA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 546 MIDDLE EAST & AFRICA: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
             TABLE 547 MIDDLE EAST & AFRICA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
             TABLE 548 MIDDLE EAST & AFRICA: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
             TABLE 549 MIDDLE EAST & AFRICA: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
             TABLE 550 MIDDLE EAST & AFRICA: MARKET, BY SETTING, 2018–2021 (USD MILLION)
             TABLE 551 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
             11.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
             11.6.2 GCC COUNTRIES
                        11.6.2.1 Growing initiatives to address mental health issues to drive growth
                                      TABLE 552 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
                                      TABLE 553 GCC COUNTRIES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 554 GCC COUNTRIES: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 555 GCC COUNTRIES: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 556 GCC COUNTRIES: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 557 GCC COUNTRIES: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 558 GCC COUNTRIES: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 559 GCC COUNTRIES: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 560 GCC COUNTRIES: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 561 GCC COUNTRIES: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 562 GCC COUNTRIES: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
                                      TABLE 563 GCC COUNTRIES: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
                                      TABLE 564 GCC COUNTRIES: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 565 GCC COUNTRIES: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 566 GCC COUNTRIES: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
                                      TABLE 567 GCC COUNTRIES: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 568 GCC COUNTRIES: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
                                      TABLE 569 GCC COUNTRIES: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 570 GCC COUNTRIES: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
                                      TABLE 571 GCC COUNTRIES: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
                                      TABLE 572 GCC COUNTRIES: MARKET, BY SETTING, 2018–2021 (USD MILLION)
                                      TABLE 573 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
             11.6.3 REST OF MIDDLE EAST & AFRICA
                        TABLE 574 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
                        TABLE 575 REST OF MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 576 REST OF MIDDLE EAST & AFRICA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 577 REST OF MIDDLE EAST & AFRICA: MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 578 REST OF MIDDLE EAST & AFRICA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 579 REST OF MIDDLE EAST & AFRICA: MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 580 REST OF MIDDLE EAST & AFRICA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 581 REST OF MIDDLE EAST & AFRICA: MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 582 REST OF MIDDLE EAST & AFRICA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 583 REST OF MIDDLE EAST & AFRICA: MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 584 REST OF MIDDLE EAST & AFRICA: MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)
                        TABLE 585 REST OF MIDDLE EAST & AFRICA: MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)
                        TABLE 586 REST OF MIDDLE EAST & AFRICA: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 587 REST OF MIDDLE EAST & AFRICA: MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 588 REST OF MIDDLE EAST & AFRICA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)
                        TABLE 589 REST OF MIDDLE EAST & AFRICA: MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 590 REST OF MIDDLE EAST & AFRICA: MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)
                        TABLE 591 REST OF MIDDLE EAST & AFRICA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 592 REST OF MIDDLE EAST & AFRICA: MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)
                        TABLE 593 REST OF MIDDLE EAST & AFRICA: MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
                        TABLE 594 REST OF MIDDLE EAST & AFRICA: MARKET, BY SETTING, 2018–2021 (USD MILLION)
                        TABLE 595 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)
 
12 COMPETITIVE LANDSCAPE (Page No. - 474)
     12.1 OVERVIEW 
     12.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 34 MENTAL HEALTH SCREENING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
     12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS (2022) 
             FIGURE 35 MENTAL HEALTH SCREENING INDUSTRY: REVENUE ANALYSIS FOR KEY PLAYERS, 2018–2022
     12.4 MARKET SHARE ANALYSIS (2022) 
             12.4.1 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MENTAL HEALTH SCREENING WEARABLE DEVICES MARKET (2022)
                       FIGURE 36 MENTAL HEALTH SCREENING WEARABLE DEVICES MARKET: MARKET SHARE ANALYSIS FOR KEY PLAYERS, 2022
                       TABLE 596 MENTAL HEALTH SCREENING WEARABLE DEVICES MARKET: DEGREE OF COMPETITION
             12.4.2 MARKET RANKING ANALYSIS OF KEY PLAYERS IN MENTAL HEALTH SCREENING INDUSTRY (2022)
     12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             12.5.1 STARS
             12.5.2 PERVASIVE PLAYERS
             12.5.3 EMERGING LEADERS
             12.5.4 PARTICIPANTS
                       FIGURE 37 MENTAL HEALTH SCREENING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
             12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                       FIGURE 38 MENTAL HEALTH SCREENING INDUSTRY: COMPANY FOOTPRINT
                       TABLE 597 MENTAL HEALTH SCREENING INDUSTRY: REGION FOOTPRINT
                       TABLE 598 MENTAL HEALTH SCREENING INDUSTRY: APPLICATION FOOTPRINT
                       TABLE 599 MENTAL HEALTH SCREENING INDUSTRY: SCREENING METHOD FOOTPRINT
                       TABLE 600 MENTAL HEALTH SCREENING INDUSTRY: TECHNOLOGY FOOTPRINT
                       TABLE 601 MENTAL HEALTH SCREENING INDUSTRY: AGE GROUP FOOTPRINT
     12.6 COMPANY EVALUATION MATRIX: SMES/STARTUPS, 2023 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 DYNAMIC COMPANIES
             12.6.3 RESPONSIVE COMPANIES
             12.6.4 STARTING BLOCKS
                       FIGURE 39 MENTAL HEALTH SCREENING INDUSTRY: COMPANY EVALUATION MATRIX (SMES/START-UPS), 2023
             12.6.5 COMPETITIVE BENCHMARKING: SMES/STARTUPS, 2023
                       TABLE 602 MENTAL HEALTH SCREENING INDUSTRY: DETAILED LIST OF KEY STARTUP/SME PLAYERS
                       TABLE 603 MENTAL HEALTH SCREENING INDUSTRY: COMPETITIVE BENCHMARKING OF STARTUP/ SME PLAYERS
     12.7 VALUATION AND FINANCIAL METRICS OF MENTAL HEALTH SCREENING WEARABLE DEVICE VENDORS 
             FIGURE 40 MENTAL HEALTH SCREENING INDUSTRY: EV/EBITDA OF KEY VENDORS
             FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF MENTAL HEALTH SCREENING WEARABLE DEVICE VENDORS
     12.8 PRODUCT COMPARATIVE ANALYSIS 
             FIGURE 42 MENTAL HEALTH SCREENING INDUSTRY: BRAND/PRODUCT COMPARATIVE ANALYSIS, BY SCREENING METHOD
             12.8.1 TOTAL BRAIN PLATFORM
             12.8.2 AIBERRY MENTAL HEALTH ASSESSMENT & SCREENING
             12.8.3 HEADSPACE FOR WORK
             12.8.4 QUARTET
     12.9 COMPETITIVE SCENARIO 
             12.9.1 MENTAL HEALTH SCREENING INDUSTRY: PRODUCT LAUNCHES
                       TABLE 604 MENTAL HEALTH SCREENING INDUSTRY: PRODUCT LAUNCHES
             12.9.2 MENTAL HEALTH SCREENING MARKET: DEALS
                       TABLE 605 MENTAL HEALTH SCREENING INDUSTRY: DEALS
             12.9.3 MENTAL HEALTH SCREENING MARKET: OTHER DEVELOPMENTS
                       TABLE 606 MENTAL HEALTH SCREENING INDUSTRY: OTHER DEVELOPMENTS
 
13 COMPANY PROFILES (Page No. - 497)
     13.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             13.1.1 SONDERMIND (TOTAL BRAIN)
                       TABLE 607 SONDERMIND: COMPANY OVERVIEW
                       TABLE 608 SONDERMIND: DEALS
                       TABLE 609 SONDERMIND: EXPANSIONS
             13.1.2 RIVERSIDE COMMUNITY CARE (MINDWISE INNOVATIONS)
                       TABLE 610 RIVERSIDE COMMUNITY CARE: COMPANY OVERVIEW
             13.1.3 PROEM BEHAVIORAL HEALTH
                       TABLE 611 PROEM BEHAVIORAL HEALTH: COMPANY OVERVIEW
                       TABLE 612 PROEM BEHAVIORAL HEALTH: DEALS
                       TABLE 613 PROEM BEHAVIORAL HEALTH: OTHER DEVELOPMENTS
             13.1.4 HEADSPACE HEALTH
                       TABLE 614 HEADSPACE HEALTH: COMPANY OVERVIEW
             13.1.5 QUARTET HEALTH, INC.
                       TABLE 615 QUARTET HEALTH, INC.: COMPANY OVERVIEW
                       TABLE 616 QUARTET HEALTH, INC.: DEALS
             13.1.6 CLARIGENT HEALTH
                       TABLE 617 CLARIGENT HEALTH: COMPANY OVERVIEW
                       TABLE 618 CLARIGENT HEALTH: PRODUCT LAUNCHES
                       TABLE 619 CLARIGENT HEALTH: DEALS
             13.1.7 ELLIPSIS HEALTH, INC.
                       TABLE 620 ELLIPSIS HEALTH: COMPANY OVERVIEW
                       TABLE 621 ELLIPSIS HEALTH, INC.: DEALS
             13.1.8 ADAPTIVE TESTING TECHNOLOGIES
                       TABLE 622 ADAPTIVE TESTING TECHNOLOGIES: COMPANY OVERVIEW
             13.1.9 AIBERRY
                       TABLE 623 AIBERRY: COMPANY OVERVIEW
                       TABLE 624 AIBERRY: PRODUCT ENHANCEMENTS
             13.1.10 KINTSUGI MINDFUL WELLNESS, INC.
                        TABLE 625 KINTSUGI MINDFUL WELLNESS, INC.: COMPANY OVERVIEW
             13.1.11 THYMIA LIMITED
                        TABLE 626 THYMIA LIMITED: COMPANY OVERVIEW
             13.1.12 CANARY SPEECH, INC.
                        TABLE 627 CANARY SPEECH, INC.: COMPANY OVERVIEW
                        TABLE 628 CANARY SPEECH, INC.: DEALS
             13.1.13 MODERN LIFE, INC.
                        TABLE 629 MODERN LIFE, INC.: COMPANY OVERVIEW
             13.1.14 SONDE HEALTH, INC.
                        TABLE 630 SONDE HEALTH, INC.: COMPANY OVERVIEW
                        TABLE 631 SONDE HEALTH, INC.: PRODUCT LAUNCHES
                        TABLE 632 SONDE HEALTH, INC.: DEALS
             13.1.15 FUTURESTHRIVE
                        TABLE 633 FUTURESTHRIVE: COMPANY OVERVIEW
             13.1.16 KONINKLIJKE PHILIPS N.V.
                        TABLE 634 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
                        FIGURE 43 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
                        TABLE 635 KONINKLIJKE PHILIPS N.V.: DEALS
             13.1.17 ALPHABET INC. (FITBIT)
                        TABLE 636 ALPHABET INC.: COMPANY OVERVIEW
                        FIGURE 44 ALPHABET INC.: COMPANY SNAPSHOT (2022)
                        TABLE 637 ALPHABET INC.: PRODUCT LAUNCHES & APPROVALS
                        TABLE 638 ALPHABET INC.: DEALS
             13.1.18 RESMED INC.
                        TABLE 639 RESMED INC.: COMPANY OVERVIEW
                        FIGURE 45 RESMED INC.: COMPANY SNAPSHOT (2023)
                        TABLE 640 RESMED INC.: PRODUCT LAUNCHES
                        TABLE 641 RESMED INC.: DEALS
             13.1.19 APPLE INC.
                        TABLE 642 APPLE INC.: COMPANY OVERVIEW
                        FIGURE 46 APPLE INC.: COMPANY SNAPSHOT (2023)
                        TABLE 643 APPLE INC.: PRODUCT LAUNCHES
             13.1.20 COGNITIVE HEALTH SOLUTIONS
                        TABLE 644 COGNITIVE HEALTH SOLUTIONS: COMPANY OVERVIEW
     13.2 OTHER PLAYERS 
             13.2.1 WELLIN5 USA, INC.
             13.2.2 MOODTOOLS
             13.2.3 MOODFIT
             13.2.4 COGNIABLE
             13.2.5 WOEBOT LABS, INC.
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
14 APPENDIX (Page No. - 542)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the Mental Health Screening market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Agency for Healthcare Research and Quality (AHRQ), Primary Care Companion for CNS Disorders Journal, Centers for Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), Expert Interviews, and MarketsandMarkets Analysis.

Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital personnel, department heads, hospital directors, corporate personnel) and supply side (such as C-level and D-level executives, technology experts, software developers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Breakdown of Primary Interviews

Health Screening Market Size, and Share

Note 1: Tiers are defined based on the total revenues of companies. As of 2022, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the mental health screening market was arrived at after data triangulation from various approaches, as mentioned below. After completing each approach, a weighted average of the three approaches was taken based on the level of assumptions used in each approach.

Approach 1: Mental Health Screening Market (Revenue Share Analysis)

  • Revenues for individual companies were gathered from public sources and databases for each market segment.
  • Revenues of private companies were gathered through paid databases such as Factiva and Hoovers.
  • Shares of the mental health screening businesses of leading players were gathered from secondary sources to the extent available. In certain cases, shares have been ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, and geographic reach.
  • Individual shares or revenue estimates were validated through expert interviews.
  • The market size was then extrapolated to obtain the global market. It was further validated through expert interviews.

Approach 2: Segmental Extrapolation

Separate research approaches were followed to estimate the revenue from mental health screening tools and continuous monitoring wearable devices used for mental health screening.

  • Mental health screening tools (excluding continuous monitoring wearable devices):
  • The total number of psychiatrists in the US was determined for 2022. The percentage of psychiatrists using mental health screening tools offered by vendors was identified through extensive secondary research and validated through insights from primary interviews.
  • The average price of mental health screening tools for yearly subscriptions was considered to arrive at the US mental health screening market for clinical settings in 2022.
  • Considering the share of clinical settings, revenues of the overall market in the US were determined for 2022.
  • The US mental health screening market was extrapolated to arrive at the global market.
  • The market for continuous monitoring wearable devices:
  • The total prevalence of mental health disorders in the US was determined for 2022, and the share of people opting for assessments was identified through extensive secondary research and validated through insights from primary interviews.
  • The share of people using continuous monitoring wearable devices for mental health screening was assumed based on secondary research and insights from primary interviews.
  • The average price of continuous monitoring wearable devices was determined through secondary sources to arrive at the US market for continuous monitoring wearable devices.
  • The US market for continuous monitoring wearable devices was extrapolated to arrive at the global market for continuous monitoring wearable devices.
  • The sum of revenues from mental health screening tools and continuous monitoring wearable devices used for mental health screening provided the revenue of the global mental health screening market. The assumptions at each step were validated through primary interviews.

Approach 3: Primary Interviews

  • As a part of the primary research process, individual respondents’ insights on the market size and growth were taken during the interview (regional and global, as applicable).
  • All the responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

Data Triangulation:

After arriving at the overall market size, from the market size estimation process explained above, the Mental Health Screening market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Mental Health Screening market.

Market Definition:

Mental health screening refers to the process of assessing an individual’s mental health status to identify potential signs or symptoms of mental health conditions. It is a preliminary step in recognizing and addressing mental health concerns early on. The goal of mental health screening is to identify individuals who may be at risk of or experiencing mental health issues so that appropriate interventions, support, or further assessments can be provided.

Screening tools may include questionnaires, surveys, or interviews that assess various aspects of an individual’s mental health, such as mood, behavior, thoughts, and emotions. These screenings are often administered by healthcare professionals, counselors, or mental health providers in different settings, including schools, workplaces, clinical settings, and others.

Key Stakeholders:

  • Manufacturers of mental health screening solutions/products
  • Suppliers and distributors of mental health screening solutions/products
  • Third-party refurbishers/suppliers
  • Clinical settings
  • Educational institutions
  • Group purchasing organizations (GPOs)
  • Academic medical centers and universities
  • Corporate entities
  • Community centers
  • Government institutes
  • Market research & consulting firms
  • Contract manufacturing organizations (CMOs)
  • Venture capitalists & investors

Report Objectives

  • To define, describe, and forecast the mental health screening market by application, screening method, technology, age group, setting, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall mental health screening market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile the key players in the market and comprehensively analyze their market shares and core competencies
  • To forecast the size of the market segments with respect to five main regions: North America, the Asia Pacific, Europe, Latin America, and the Middle East & Africa
  • To track and analyze competitive developments, such as partnerships, acquisitions, and launches
  • To benchmark players within the mental health screening market using the Competitive Evaluation Matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Additional Company Profiling

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Europe mental health screening market into Spain, Italy, Russia, and others
  • Further breakdown of the Rest of Asia Pacific mental health screening market into Australia, South Korea, Singapore, and others
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
HIT 8966
Published ON
Mar, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Mental Health Screening Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback